UBS Group
OSCR icon

UBS Group’s Oscar Health OSCR Stock Holding History

UBS Group’s Portfolio OSCR Stock Details OSCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.6M Sell
1,213,056
-361,922
-23% -$7.79M ﹤0.01% 2109
2026
Q1 		$18.1M Buy
1,574,978
+340,881
+28% +$4.8M ﹤0.01% 2704
2025
Q4 		$17.7M Sell
1,234,097
-1,276,373
-51% -$22.1M ﹤0.01% 2698
2025
Q3 		$47.5M Buy
2,510,470
+1,524,836
+155% +$25.1M 0.01% 1678
2025
Q2 		$21.1M Sell
985,634
-80,015
-8% -$1.19M ﹤0.01% 2304
2025
Q1 		$14M Sell
1,065,649
-134,358
-11% -$1.99M ﹤0.01% 2710
2024
Q4 		$16.1M Buy
1,200,007
+447,163
+59% +$7.2M ﹤0.01% 2562
2024
Q3 		$16M Buy
752,844
+136,186
+22% +$2.45M ﹤0.01% 2006
2024
Q2 		$9.76M Sell
616,658
-26,900
-4% -$494K ﹤0.01% 2231
2024
Q1 		$9.57M Sell
643,558
-505,052
-44% -$6.92M ﹤0.01% 2309
2023
Q4 		$10.5M Sell
1,148,610
-340,888
-23% -$2.35M ﹤0.01% 2049
2023
Q3 		$8.3M Buy
1,489,498
+683,052
+85% +$4.78M ﹤0.01% 2130
2023
Q2 		$6.5M Sell
806,446
-459,618
-36% -$3.39M ﹤0.01% 2333
2023
Q1 		$8.28M Sell
1,266,064
-848,714
-40% -$3.46M ﹤0.01% 2041
2022
Q4 		$5.2M Buy
2,114,778
+1,216,118
+135% +$3.8M ﹤0.01% 2464
2022
Q3 		$4.48M Buy
898,660
+305,182
+51% +$1.78M ﹤0.01% 2463
2022
Q2 		$2.52M Sell
593,478
-49,616
-8% -$316K ﹤0.01% 2944
2022
Q1 		$6.41M Sell
643,094
-107,002
-14% -$796K ﹤0.01% 2303
2021
Q4 		$5.89M Buy
750,096
+684,128
+1,037% +$8.59M ﹤0.01% 2648
2021
Q3 		$1.15M Buy
65,968
+60,700
+1,152% +$1.03M ﹤0.01% 4074
2021
Q2 		$113K Buy
+5,268
New +$126K ﹤0.01% 5782

Other funds holding OSCR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
TCMNY
Thrive Capital Management (New York) New York $3.81B AUM 45.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group's OSCR Position: Q2 2026 in Review

UBS Group reduced its Oscar Health (OSCR) stake by 23% in Q2 2026, selling an estimated $7.79M and leaving 1,213,056 shares worth $34.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2109.

UBS Group first reported a position in OSCR in Q2 2021 and has held it in 21 quarters since. The position peaked at $47.5M in Q3 2025. 402 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • UBS Group held 1,213,056 shares of Oscar Health worth $34.6M as of Q2 2026.
  • UBS Group sold 361,922 Oscar Health shares in Q2 2026, an estimated $7.79M.
  • Oscar Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2109 holding.
  • UBS Group first reported a position in Oscar Health in Q2 2021 and has held it in 21 quarters since.
  • UBS Group's Oscar Health position peaked at $47.5M in Q3 2025.
  • 402 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.